What Is the Best Non-Prescription Weight Loss Pill?

The only non-prescription weight loss pill with full FDA approval is Alli (orlistat 60 mg), which blocks about 25% of the fat you eat from being absorbed. In clinical studies, people who combined Alli with a calorie-restricted diet and exercise lost an average of 5.7 extra pounds over one year compared to diet and exercise alone. That’s modest, and it’s still the strongest evidence available for any over-the-counter option. Several supplement ingredients show small effects in clinical trials, but none come close to what you’d get from prescription medications.

Alli: The Only FDA-Approved OTC Option

Alli contains orlistat at 60 mg, exactly half the dose of the prescription version. It’s approved for adults 18 and older with a BMI of 25 or more. You take one pill within an hour of a fat-containing meal, up to three times a day. The drug works by disabling a digestive enzyme that breaks down dietary fat, so a portion passes through your body unabsorbed.

In some studies, more than 40% of people taking Alli alongside a reduced-calorie diet and regular exercise lost 5% or more of their body weight within a year. That 5% threshold is where doctors start seeing meaningful reductions in risk for heart disease and diabetes. The side effects are directly tied to the mechanism: eating too much fat while on Alli causes oily stools, gas, and urgent bowel movements. Most people learn quickly to keep meals lower in fat, which itself contributes to the calorie reduction.

One serious but rare concern is liver injury. The FDA identified 13 total postmarketing reports of severe liver damage across both the prescription and OTC versions, including cases that led to liver transplant or death. The risk is very low relative to the millions of people who have used the drug, but it led the FDA to add a warning to the label. If you notice yellowing skin, dark urine, or persistent stomach pain while taking Alli, stop using it immediately.

White Kidney Bean Extract

White kidney bean extract works on a completely different principle than Alli. Instead of blocking fat, it inhibits the enzyme that digests starch, reducing how many carbohydrate calories your body actually absorbs. A review of human studies published in the journal Nutrients found that participants taking the extract lost an average of 2.6 kg (about 5.7 pounds), with results ranging from 1.8 to 3.5 kg across different trials.

The more convincing studies ran for about 12 weeks. In one randomized, placebo-controlled trial over 84 days, participants on a reduced-calorie diet who took white kidney bean extract lost 2.9 kg compared to just 0.9 kg in the placebo group. They also lost more fat mass and more inches from the waist. Another 84-day trial found a 3.5 kg reduction in body weight and a 2.3% drop in body fat percentage. These numbers are in the same ballpark as Alli, though the trials were shorter and involved fewer participants. Doses in successful studies typically ranged from about 445 mg to 3,000 mg per day.

Green Tea Extract

Green tea extract is one of the most common ingredients in weight loss supplements, usually because of its combination of caffeine and catechins (plant compounds with antioxidant activity). A Cochrane systematic review, which is considered the gold standard for evaluating evidence, pooled results from 11 randomized trials and found that people taking green tea extract lost an average of 1.31 kg (about 2.9 pounds) more than those on placebo.

That’s a real but very small effect. A separate analysis within the same review noted that the effect is “not likely to be clinically relevant.” When researchers looked only at studies where caffeine alone was the active ingredient, the difference in weight loss disappeared entirely. So the catechins may contribute something, but you shouldn’t expect green tea extract to move the needle much on its own.

CLA (Conjugated Linoleic Acid)

CLA is a fatty acid found naturally in meat and dairy, sold in capsule form as a weight loss supplement. A meta-analysis of seven randomized trials lasting at least six months found a statistically significant but tiny advantage: people taking CLA lost just 0.70 kg (about 1.5 pounds) more than those on placebo. Fat loss specifically was slightly better at 1.33 kg, suggesting CLA may have a small effect on body composition rather than overall weight. The researchers concluded that the clinical relevance of these effects is uncertain. Side effects include constipation, diarrhea, and soft stools.

Glucomannan

Glucomannan is a soluble fiber derived from the konjac root that expands in your stomach, theoretically making you feel fuller. It appears in many “appetite suppressant” products. Despite its popularity, a well-designed randomized trial using 3.99 grams per day for eight weeks found no significant difference between glucomannan and placebo. The glucomannan group lost 0.40 kg and the placebo group lost 0.43 kg, essentially identical results. Earlier, smaller studies had shown more promise, but this controlled trial suggests the fiber alone isn’t enough to drive meaningful weight loss.

Berberine

Berberine is a plant compound that has gained attention partly because it activates some of the same cellular pathways as the diabetes drug metformin. A 2024 meta-analysis pooling eight randomized placebo-controlled trials (684 participants total) found that berberine reduced BMI by 0.435 points compared to placebo. That’s a real effect, but it translates to only a few pounds for most people. Berberine may be more useful for its effects on blood sugar and cholesterol than for weight loss specifically.

Why the Supplement Market Is Risky

Unlike prescription drugs or even Alli, most weight loss supplements don’t undergo FDA review before they hit shelves. The Dietary Supplement Health Education Act of 1994 created a system where manufacturers can sell products without proving they work or proving they’re safe. The Endocrine Society, the leading professional organization for hormone and metabolism researchers, has stated bluntly that evidence supporting the effectiveness or safety of over-the-counter herbal weight loss preparations “is usually nonexistent.”

The FDA maintains an active list of weight loss products found to contain hidden, undeclared drug ingredients. As of mid-2025, the agency has flagged products including FATZorb, Toki Slimming Candy, LipoFit Turbo, and dozens of others for containing dangerous hidden ingredients not listed on their labels. These contaminated products sometimes contain banned pharmaceutical compounds at unpredictable doses. If a weight loss supplement promises dramatic results or sounds too good to be true, that’s a strong signal to check the FDA’s tainted products database before buying.

Putting the Numbers in Perspective

Here’s a realistic summary of what the clinical evidence actually supports for the most-studied options:

  • Alli (orlistat 60 mg): About 5.7 extra pounds lost over one year versus diet and exercise alone. FDA-approved, well-studied, common GI side effects.
  • White kidney bean extract: About 2 to 5.7 extra pounds over 8 to 12 weeks in controlled trials. Fewer large-scale studies than Alli.
  • Green tea extract: About 2.9 extra pounds on average. Effect is small and may not be clinically meaningful.
  • CLA: About 1.5 extra pounds over six months or more. Clinical relevance uncertain.
  • Glucomannan: No significant weight loss beyond placebo in controlled trials.
  • Berberine: Small BMI reduction of less than half a point. More promising for blood sugar control.

None of these numbers are transformative on their own. Prescription GLP-1 medications, by comparison, routinely produce 15% to 20% body weight loss in clinical trials, but they cost $150 to $300 or more per month and require a prescription. The gap between what’s available over the counter and what’s available by prescription is wide. If you’re considering an OTC weight loss pill, the honest expectation is a few extra pounds lost over several months, always on top of dietary changes and physical activity, never as a replacement for them.